Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Comment by macbethorfauston May 08, 2009 12:33pm
316 Views
Post# 15978398

RE: RE: Cash infusion, my wiew only

RE: RE: Cash infusion, my wiew onlyhmmm, you got my attenae up chemnai - typically someone as negative on a stock as you appear to be doesn't hang around, i mean why would you

First of all, let's get the facts straight - Voclo is not inferior in efficacy to cyclo and it is disingenuous to say that - voclo at the very specific dosage that they utilized in the European studies (which, as with all these tests, is in part a dose finding study) is not as effectual as cyclo (at its typical dosage) for a minority of patients - dial it up and it is every bit as effective and safety wise there is a lot of room. Also Paladin wouldn't have undertaken to apply for Canadian NDA unless is was pretty sure it was going to get it; granted, it is still ahead if it doesn't get it because of the tax losses, but having to announce a failed NDA application a year from now is hardly going to do its share price any good.

Second, there may not be much more needed for NDA in Europe although another US phase III for the US for sure - clearly they need other partners if they want to go full board in the US and Europe simultaneously and definitely to proceed with transplant, or else they are going to have to wait for milestones from Lux to do this - I don't know how much $7M buys you towards NDA in Europe alone although I would have thought a lot.  I would bet a very expensive scotch that they are already in discussions with other partners to partner on a geographical basis. 
Bullboard Posts